This compound is a protected ornithine derivative used as an intermediate in solid-phase peptide synthesis. It features both Boc and Fmoc protecting groups, enabling selective deprotection during peptide chain assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 150828-96-9
N-Boc-N'-Fmoc-L-Lysine
research compound
N-Fmoc-N'-Boc-L-Lysine
pharmaceutical intermediate
FMOC-D-Lys(BOC)-OH
research compound
N-Fmoc-N'-Boc-L-2,4-diaminobutyric acid
pharmaceutical intermediate
(S)-2-((S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-METHYLBUTANAMIDO)-5-UREIDOPENTANOIC ACID
pharmaceutical intermediate
(23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
pharmaceutical intermediate
N-Boc-N'-Fmoc-D-2,3-diaminopropionic acid
pharmaceutical intermediate
Fmoc-L-cysteine
pharmaceutical intermediate
(2S)-5-(9H-fluoren-9-ylmethoxycarbonylamino)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
YEBWACZYMHWWEK-NRFANRHFSA-N
CC(C)(C)OC(=O)N[C@@H](CCCNC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)O